Hearing Loss Trial, Recruiting NCT05985473 Sponsor: Institut Pasteur Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT05985473
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People whose first language (mother tongue) is French
  • People with little to no measurable hearing loss — specifically, an average hearing loss of less than 30 dB in each ear when tested individually with headphones (confirm with trial site for exact testing method)
  • People who are currently employed and not pre-retired or unemployed
  • People who are enrolled in a French social security plan

For participants with a specific type of listening difficulty (referred to as TSNA):

  • People whose ability to understand speech in noisy environments is noticeably below the normal range (confirm with trial site for exact threshold details)

For control group participants:

  • People whose ability to understand speech in noisy environments falls within the normal range (confirm with trial site for exact threshold details)

Who may not be able to join:

  • People whose hearing loss originates in the outer or middle ear, or a combination of that and the inner ear (rather than the inner ear alone)
  • People with a significant difference in hearing ability between their left and right ears — specifically, more than 30 dB difference on average
  • People with lasting effects from ear infections, or a history of certain ear or balance conditions such as vestibular schwannoma, Meniere's disease, sudden or fluctuating hearing loss, or hearing loss present from birth
  • People who are under legal guardianship
  • People whose freedom is restricted by a court or government decision, or who are under a legal protection order

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Paul Avan, MD, CEntre de Recherche et d'Innovation en Audiologie Humain

Phone: ++33 (0) 1 76 53 51 12

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institut Pasteur
Registry
ClinicalTrials.gov
Start date
6 March 2024
Est. completion
15 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Comparison of percentage of words correctly repeated by participants (ANSD and controls)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov